Neuralstem Begins Phase II Trial Using NSI-566 Spinal Cord-Derived Neural Stem …

Published September 13, 2013

Neuralstem begins phase II trial using NSI-566 spinal cord-derived neural stem …
Neuralstem, Inc. has treated its first patient in phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at Emory University Hospital in Atlanta, Georgia. The … Read more on pharmabiz.com

Civil rights pioneer now crusades against cancer
Dennis was in college then, and recalled: “I had to work, could not get provisions to leave so I celebrated that march from Atlanta, Ga. “That day, that weekend, it has always been deep in my spirit and my mind and forever will be.” Dr. Lombard's … Read more on Glencoe News

Georgia Research Alliance names Winship Cancer Institute director a GRA …
In 2012 the Brain Tumor Foundation for Children honored Curran with a "Visionary Award" for helping bring a proton beam therapy treatment center to Atlanta. The center, which is the first in Georgia and one of only a dozen in the United States, is … Read more on Emory University News and Events